After 10 long years, the company that has developed a collagen biomaterial to help heal tissue is readying itself for its ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Mean duration of Crohn's disease was 7.4 years. Nearly half (48.5%) had previous biologic therapy failure, 45.7% had previous ...

From additional regulatory requirements to transport refusal, the field of radiopharmaceutical trials can face additional red ...

Mark Plemmons' Friday Five includes Page Castrodale leaving the Cabarrus EDC for a job with Eli Lilly, N.C. Sen. Paul Newton ...

We are grateful to our colleagues for their interest and thoughtful comments on our Seminar about systemic lupus erythematosus (SLE).1 We appreciate the remarks from Qihe Xu, and Thomas Pabst and ...

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion ...

Eli Lilly’s strong position in GLP-1 drugs is overlooked by the market. Find out why LLY stock is a buy even as others pull ...

One of the Charlotte region's top economic development players has been hired by a pharmaceutical giant establishing a ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

CFO to depart at year-end in move that comes after CEO exited in September WW International Inc., the company known as ...

Eli Lilly and Company chief corporate brand officer Lina Polimeni described the new format as a “big evolution” in the ...